Adaptive Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,347	2,497	887	711	1,093	3,968
Market Cap Growth	106.84%	181.67%	24.72%	-34.98%	-72.44%	-51.25%
Enterprise Value	3,460	2,356	753.51	463.15	703.06	3,726
Last Close Price	20.91	16.24	6.00	4.90	7.64	28.06
PS Ratio	11.81	9.02	4.95	4.18	5.90	25.71
PB Ratio	16.09	11.41	4.37	2.31	2.36	6.57
P/TBV Ratio	33.95	25.12	10.99	3.84	3.22	8.27
EV/Sales Ratio	11.71	8.51	4.21	2.72	3.79	24.14
Debt / Equity Ratio	0.31	0.31	0.39	0.29	0.21	0.18
Net Debt / Equity Ratio	-0.65	-0.68	-0.66	-0.80	-0.84	-0.40
Net Debt / EBITDA Ratio	4.72	3.76	0.93	1.21	2.18	1.24
Net Debt / FCF Ratio	4.76	3.02	1.34	1.48	1.95	0.95
Asset Turnover	0.58	0.53	0.30	0.22	0.21	0.15
Inventory Turnover	6.95	7.82	6.30	5.23	3.44	2.96
Quick Ratio	3.06	3.08	2.69	4.37	4.90	3.26
Current Ratio	3.35	3.34	2.89	4.66	5.12	3.54
Return on Equity (ROE)	-22.10%	-27.82%	-62.49%	-58.34%	-37.52%	-30.77%
Return on Assets (ROA)	-9.17%	-10.86%	-27.08%	-29.92%	-22.49%	-20.49%
Return on Invested Capital (ROIC)	-58.15%	-77.85%	-249.64%	-337.47%	-91.68%	-79.51%
Return on Capital Employed (ROCE)	-11.10%	-13.22%	-32.05%	-34.40%	-25.72%	-22.95%
Buyback Yield / Dilution	-3.62%	-3.14%	-1.88%	-1.31%	-1.54%	-6.96%
Total Shareholder Return	-3.62%	-3.14%	-1.88%	-1.31%	-1.54%	-6.96%

SEC Filings: 10-K · 10-Q